Literature DB >> 23962911

PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 8.

Christina L Aquilante1, Mikko Niemi, Li Gong, Russ B Altman, Teri E Klein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23962911      PMCID： PMC4038626          DOI： 10.1097/FPC.0b013e3283653b27

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN： 1744-6872            Impact factor:   2.089


× No keyword cloud information.
  150 in total

1.  Influence of CYP2C8*13 and CYP2C8*14 alleles on amiodarone N-deethylation.

Authors:  Nobumitsu Hanioka; Kimiaki Matsumoto; Yoshiro Saito; Shizuo Narimatsu
Journal:  Basic Clin Pharmacol Toxicol       Date:  2011-01-31       Impact factor: 4.080

2.  Amodiaquine clearance and its metabolism to N-desethylamodiaquine is mediated by CYP2C8: a new high affinity and turnover enzyme-specific probe substrate.

Authors:  Xue-Qing Li; Anders Björkman; Tommy B Andersson; Marianne Ridderström; Collen M Masimirembwa
Journal:  J Pharmacol Exp Ther       Date:  2002-02       Impact factor: 4.030

3.  CYP2C8 status of patients with malaria influences selection of Plasmodium falciparum pfmdr1 alleles after amodiaquine-artesunate treatment.

Authors:  Isa Cavaco; Andreas Mårtensson; Gabrielle Fröberg; Mwinyi Msellem; Anders Björkman; José P Gil
Journal:  J Infect Dis       Date:  2012-11-30       Impact factor: 5.226

4.  Gemfibrozil markedly increases the plasma concentrations of montelukast: a previously unrecognized role for CYP2C8 in the metabolism of montelukast.

Authors:  T Karonen; A Filppula; J Laitila; M Niemi; P J Neuvonen; J T Backman
Journal:  Clin Pharmacol Ther       Date:  2010-06-30       Impact factor: 6.875

5.  Oxidation of troglitazone to a quinone-type metabolite catalyzed by cytochrome P-450 2C8 and P-450 3A4 in human liver microsomes.

Authors:  H Yamazaki; A Shibata; M Suzuki; M Nakajima; N Shimada; F P Guengerich; T Yokoi
Journal:  Drug Metab Dispos       Date:  1999-11       Impact factor: 3.922

6.  The effect of the cytochrome P450 CYP2C8 polymorphism on the disposition of (R)-ibuprofen enantiomer in healthy subjects.

Authors:  Carmen Martínez; Elena García-Martín; Gerardo Blanco; Francisco J G Gamito; José M Ladero; José A G Agúndez
Journal:  Br J Clin Pharmacol       Date:  2005-01       Impact factor: 4.335

7.  Variability in human cytochrome P450 paclitaxel metabolism.

Authors:  D S Sonnichsen; Q Liu; E G Schuetz; J D Schuetz; A Pappo; M V Relling
Journal:  J Pharmacol Exp Ther       Date:  1995-11       Impact factor: 4.030

8.  Identification of CYP3A4 and CYP2C8 as the major cytochrome P450 s responsible for morphine N-demethylation in human liver microsomes.

Authors:  D Projean; P-E Morin; T M Tu; J Ducharme
Journal:  Xenobiotica       Date:  2003-08       Impact factor: 1.908

9.  Expression and induction of CYP2C P450 enzymes in primary cultures of human hepatocytes.

Authors:  Judy L Raucy; Lisa Mueller; Kui Duan; Scott W Allen; Stephen Strom; Jerome M Lasker
Journal:  J Pharmacol Exp Ther       Date:  2002-08       Impact factor: 4.030

10.  Global variation in CYP2C8-CYP2C9 functional haplotypes.

Authors:  William C Speed; Soonmo Peter Kang; David P Tuck; Lyndsay N Harris; Kenneth K Kidd
Journal:  Pharmacogenomics J       Date:  2009-04-21       Impact factor: 3.550
View more
  16 in total

Review 1.  Pharmacogenetics in Jewish populations.

Authors:  Yao Yang; Inga Peter; Stuart A Scott
Journal:  Drug Metabol Drug Interact       Date:  2014

Review 2.  Genetic determinants of fetal opiate exposure and risk of neonatal abstinence syndrome: Knowledge deficits and prospects for future research.

Authors:  T Lewis; J Dinh; J S Leeder
Journal:  Clin Pharmacol Ther       Date:  2015-07-22       Impact factor: 6.875

3.  Preemptive Genotyping of CYP2C8 and CYP2C9 Allelic Variants Involved in NSAIDs Metabolism for Sickle Cell Disease Pain Management.

Authors:  Cheedy Jaja; Latanya Bowman; Leigh Wells; Niren Patel; Hongyan Xu; Matt Lyon; Abdullah Kutlar
Journal:  Clin Transl Sci       Date:  2015-02-02       Impact factor: 4.689

4.  Developmental Pharmacogenetics of SLCO2B1 on Montelukast Pharmacokinetics in Chinese Children.

Authors:  Qian Li; Kai Wang; Jun Zhou; Wei Zhao; Hai-Yan Shi; Yue-E Wu; Yue Zhou; Min Kan; Yi Zheng; Guo-Xiang Hao; Xin-Mei Yang; Yi-Lei Yang; Le-Qun Su; Xiao-Ling Wang; Evelyne Jacqz-Aigrain
Journal:  Drug Des Devel Ther       Date:  2019-12-27       Impact factor: 4.162

5.  The influence of CYP2C8*3 on carbamazepine serum concentration in epileptic pediatric patients.

Authors:  D D Milovanovic; J R Milovanovic; M Radovanovic; I Radosavljevic; S Obradovic; S Jankovic; D Milovanovic; N Djordjevic
Journal:  Balkan J Med Genet       Date:  2016-08-02       Impact factor: 0.519

6.  Comprehensive Pharmacogenomic Study Reveals an Important Role of UGT1A3 in Montelukast Pharmacokinetics.

Authors:  Päivi Hirvensalo; Aleksi Tornio; Mikko Neuvonen; Tuija Tapaninen; Maria Paile-Hyvärinen; Vesa Kärjä; Ville T Männistö; Jussi Pihlajamäki; Janne T Backman; Mikko Niemi
Journal:  Clin Pharmacol Ther       Date:  2017-11-06       Impact factor: 6.875

Review 7.  Role of Genetic Variations in the Hepatic Handling of Drugs.

Authors:  Jose J G Marin; Maria A Serrano; Maria J Monte; Anabel Sanchez-Martin; Alvaro G Temprano; Oscar Briz; Marta R Romero
Journal:  Int J Mol Sci       Date:  2020-04-20       Impact factor: 5.923

8.  Assessment of coding region variants in Kuwaiti population: implications for medical genetics and population genomics.

Authors:  Sumi Elsa John; Dinu Antony; Muthukrishnan Eaaswarkhanth; Prashantha Hebbar; Arshad Mohamed Channanath; Daisy Thomas; Sriraman Devarajan; Jaakko Tuomilehto; Fahd Al-Mulla; Osama Alsmadi; Thangavel Alphonse Thanaraj
Journal:  Sci Rep       Date:  2018-11-08       Impact factor: 4.379

9.  Evaluation of clinical and genetic factors in the population pharmacokinetics of carbamazepine.

Authors:  Vincent L M Yip; Henry Pertinez; Xiaoli Meng; James L Maggs; Daniel F Carr; B Kevin Park; Anthony G Marson; Munir Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  2020-12-14       Impact factor: 4.335

Review 10.  Repurposing Drugs to Treat Heart and Brain Illness.

Authors:  Maranda S Cantrell; Alejandro Soto-Avellaneda; Jackson D Wall; Aaron D Ajeti; Brad E Morrison; Lisa R Warner; Owen M McDougal
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.